Tobacco, alcohol, and human papillomavirus (HPV) are major risk factors for head and neck cancer (HNC), but it is unclear whether there are two distinct HNC risk groups, one associated with HPV and the other with tobacco/alcohol. Because HPV-positive HNC are clinically distinct from HPV-negative cases in treatment response and with more favorable prognoses, determining whether these differences result from infection alone or in association with other HNC risk factors is important for developing future therapeutic strategies. Incident cases of HNC (n = 201) and age-gender frequency-matched controls (n = 324) were recruited to assess anti-HPV VLP (virus like particles) antibodies 16, 18, 31, and 33. Multivariate logistic regression and stratified analyses were used to calculate adjusted odds ratios (OR). HPV-seronegative and seropositive/heavy tobacco users had similar increased adjusted risks of HNC (HPV-seronegative OR = 2.6, 1.4–5.0; HPV-seropositive OR = 2.3, 1.1–4.8), as did HPV-seronegative (OR = 4.3, 2.1–9.1) versus HPV-seropositive/heavy alcohol users (OR = 3.9, 1.6–9.4). Similar HPV/tobacco/alcohol risk profiles also were seen in oropharyngeal and oral cavity tumor sites. Our finding that tobacco/alcohol use increased the risk of HNC in both HPV-seropositive and HPV-seronegative individuals is consistent with the observation that HPV infection is not a sufficient cause of HNC but requires the accumulation of additional cellular changes.
Head and neck neoplasms Tobacco Alcohol Human papillomavirus HPV VLP
This is a preview of subscription content, log in to check access.
This study was supported by NIH DE13110 (EMS, LMR, THH, LPT), DE1311-S1 (EMS, LMR, THH, EH, LPT), Veterans Affairs Merit Review Funds (THH, LPT).
Franceschi S, Talamini R, Baria S et al (1990) Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res 50(20):6502–6507PubMedGoogle Scholar
Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48(11):3282–3287PubMedGoogle Scholar
Smith EM, Ritchie JM, Summersgill KF et al (2004) Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96(6):449–455CrossRefPubMedGoogle Scholar
Kreimer AR, Clifford GM, Boyle P et al (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14(2):467–475CrossRefGoogle Scholar
Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720CrossRefPubMedGoogle Scholar
Gillison ML, D’Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407–420CrossRefPubMedGoogle Scholar
Applebaum KM, Furniss CS, Zeka A et al (2007) Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 99(23):1801–1810CrossRefPubMedGoogle Scholar
Schwartz SM, Daling JR, Doody DR et al (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90(21):1626–1636CrossRefPubMedGoogle Scholar
Herrero R, Castellsaque X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Instit 95(23):1772–1783Google Scholar
Dahlstrom KR, Little JA, Zafereo ME et al (2008) Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 30(1):75–84CrossRefPubMedGoogle Scholar
Psyrri A, DiMaio D (2008) Human papillomavirus in cervical and head-and-neck-cancer. Nat Clin Prac Oncol 5(1):24–31CrossRefGoogle Scholar
American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edn. Lippincott Williams and Wilkins, ChicagoGoogle Scholar
Smith EM, Rubenstein LM, Ritchie JM et al (2008) Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomark Prev 17(8):2087–2096CrossRefGoogle Scholar
Hamšíková E, Ludvíková V, Smahel M et al (1998) Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer 77(5):689–694CrossRefPubMedGoogle Scholar
Summersgill KF, Smith EM, Kirchner HL et al (2000) p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90(3):334–339CrossRefPubMedGoogle Scholar
Chehab FF, Doherty M, Cai SP et al (1987) Detection of sickle cell anaemia and thalassaemias [letter]. Nature 329(6141):293–294CrossRefPubMedGoogle Scholar
Ting Y, Manos MM (1990) Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols, a guide to methods and applications. Academic Press, Berkeley, pp 356–367Google Scholar
Hildesheim A, Schiffman MH, Gravitt PE et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infec Dis 169(2):235–240Google Scholar
de Roda Husman A-M, Walboomers JMM, van den Brule AJC et al (1995) The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062CrossRefPubMedGoogle Scholar
Altschul SF, Madden TL, Schaeffer AA et al (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 25(17):3389–3402CrossRefPubMedGoogle Scholar